Parabolic Technologies Hit With Nasdaq Delisting Determination After 1-for-2,000 Cumulative Reverse Splits

summarizeSummary

Parabolic Technologies received a Nasdaq Staff Delisting Determination after cumulative 1-for-2,000 reverse splits disqualified it from the standard 180-day cure period; trading suspends November 5, 2026 unless it appeals by November 3. Shareholders separately approved expanding authorized shares to 850 million and clearing Nasdaq 5635(d) votes for a potential offering and Evergreen note/warrant conversions.

check_boxKey Events · Legal and Risk Events · PARA

• Nasdaq Issues Delisting Determination

  On October 27, 2026 Nasdaq notified the company its bid price sat below $1.00 for 30 consecutive business days (September 15 – October 26, 2026), breaching Listing Rule 5550(a)(2).

• No Cure Period Due to Split History

  Rule 5810(c)(3)(A)(iv) denies the normal 180-day compliance window because of a 1-for-10 split on July 8, 2025, a 1-for-20 on May 8, 2026 and a 1-for-10 on October 27, 2026 — a cumulative 1-for-2,000 ratio.

• November 5 Suspension Deadline

  Trading suspends at the open on November 5, 2026 and a Form 25-NSE follows unless a hearing request and the $20,000 fee reach Nasdaq by 4:00 p.m. ET on November 3, 2026; the company says it intends to appeal, which would stay the suspension.

• Authorized Shares Raised to 850 Million

  A Certificate of Amendment effective 12:01 a.m. ET October 30, 2026 lifts authorized stock to 850,000,000 shares from 350,000,000 — 750,000,000 Class A, 25,000,000 Class B and 75,000,000 preferred. This is authorization only; no shares were sold.

auto_awesomeAnalysis · PARA · Technology

Nasdaq's Staff Delisting Determination is the dominant fact here: because Parabolic has now done three reverse splits in under two years (1-for-10 in July 2025, 1-for-20 in May 2026, 1-for-10 on October 27, 2026 — a cumulative 1-for-2,000), the exchange stripped away the usual 180-day cure period. Trading is suspended at the open on November 5, 2026 unless the company files a hearing request and pays a $20,000 fee by 4:00 p.m. ET on November 3, 2026. A timely appeal stays the suspension, but the company must convince a Hearings Panel that the October 27 reverse split will actually hold the bid above $1.00 — a split that has already failed twice. Against that backdrop, shareholders approved raising authorized shares to 850 million from 350 million and cleared the Nasdaq 5635(d) votes for a potential public offering and for Evergreen Capital Management's note and warrant conversions. That is permission to issue stock, not stock sold: the expanded authorization creates substantial dilution headroom the company will likely need to fund operations, but no shares have been issued under it. The combination — a delisting clock running alongside freshly expanded share capacity — points to a company that is running out of both time and options.